{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:40:09Z","timestamp":1793364009116,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T00:00:00Z","timestamp":1360713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s10147-013-0534-9","type":"journal-article","created":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T04:26:21Z","timestamp":1360643181000},"page":"133-138","source":"Crossref","is-referenced-by-count":16,"title":["Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer"],"prefix":"10.1007","volume":"19","author":[{"given":"Sota","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Kaiho-Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Toyoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Niikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Yaegashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,13]]},"reference":[{"key":"534_CR1","unstructured":"Center for Cancer Control and Information Services (2011) Vital Statistics Japan edited by Ministry of Health, Labour and Welfare. National Cancer Center. Available via DIALOG. http:\/\/ganjoho.jp\/professional\/statistics\/statistics (page 17)"},{"issue":"2","key":"534_CR2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10147-010-0061-x","volume":"15","author":"S Nagase","year":"2010","unstructured":"Nagase S, Inoue Y, Umesaki N et al (2010) Evidence-based guidelines for treatment of cervical cancer in Japan. Japan Society of Gynecologic Oncology (JSGO) 2007 edition. Int J Clin Oncol 15(2):117\u2013124","journal-title":"Int J Clin Oncol"},{"key":"534_CR3","doi-asserted-by":"crossref","unstructured":"Rose PG, Bundy BN, Watkins EB et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 15;340(15):1144\u20131153 (Erratum in: N Engl J Med 1999 26;341(9):708)","DOI":"10.1056\/NEJM199904153401502"},{"issue":"5","key":"534_CR4","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.1998.16.5.1879","volume":"16","author":"KR Brader","year":"1998","unstructured":"Brader KR, Morris M, Levenback C et al (1998) Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol 16(5):1879\u20131884","journal-title":"J Clin Oncol"},{"key":"534_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO;2-A","volume":"1","author":"A Brunschwig","year":"1948","unstructured":"Brunschwig A (1948) Complete excision of the pelvic viscera for advanced carcinoma. Cancer 1:177\u2013183","journal-title":"Cancer"},{"key":"534_CR6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ygyno.2005.05.034","volume":"99","author":"JS Berek","year":"2005","unstructured":"Berek JS, Howe C, Lagasse LD et al (2005) Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol Oncol 99:153\u2013159","journal-title":"Gynecol Oncol"},{"key":"534_CR7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2009.03.029","volume":"114","author":"A Maggioni","year":"2009","unstructured":"Maggioni A, Roviglione G, Landoni F et al (2009) Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol 114:64\u201368","journal-title":"Gynecol Oncol"},{"key":"534_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2009.09.035","volume":"116","author":"M Jurado","year":"2010","unstructured":"Jurado M, Alcazar JL, Martinez-Monge R et al (2010) Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? A twenty-year experience. Gynecol Oncol 116:38\u201343","journal-title":"Gynecol Oncol"},{"issue":"1","key":"534_CR9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2010.11.044","volume":"121","author":"KA McLean","year":"2011","unstructured":"McLean KA, Zhang W, Dunsmoor-Su RF et al (2011) Pelvic exenteration in the age of modern chemoradiation. Gynecol Oncol 121(1):131\u2013134","journal-title":"Gynecol Oncol"},{"issue":"1","key":"534_CR10","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ygyno.2011.09.031","volume":"124","author":"F Khoury-Collado","year":"2012","unstructured":"Khoury-Collado F, Einstein MH, Bochner BH et al (2012) Pelvic exenteration with curative intent for recurrent uterine malignancies. Gynecol Oncol 124(1):42\u201347","journal-title":"Gynecol Oncol"},{"key":"534_CR11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2007.03.018","volume":"106","author":"A Husain","year":"2007","unstructured":"Husain A, Akhurst T, Larson S et al (2007) A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecol Oncol 106:177\u2013180","journal-title":"Gynecol Oncol"},{"issue":"1","key":"534_CR12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0090-8258(03)00256-7","volume":"90","author":"LJ Havrilesky","year":"2003","unstructured":"Havrilesky LJ, Wong TZ, Secord AA et al (2003) The role of PET scanning in the detection of recurrent cervical cancer. Gynecol Oncol 90(1):186\u2013190","journal-title":"Gynecol Oncol"},{"key":"534_CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0090-8258(87)90029-1","volume":"26","author":"FN Rutledge","year":"1987","unstructured":"Rutledge FN, McGuffee VB (1987) Pelvic exenteration: prognostic significance of regional lymph node metastasis. Gynecol Oncol 26:347\u2013380","journal-title":"Gynecol Oncol"},{"key":"534_CR14","first-page":"934","volume":"74","author":"GW Morely","year":"1989","unstructured":"Morely GW, Hopkins MP, Lindennaur SM et al (1989) Pelvic exenteration, University of Michigan: 100 patients at 5\u00a0years. Obstet Gynecol 74:934\u2013942","journal-title":"Obstet Gynecol"},{"key":"534_CR15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0140-6736(95)91146-4","volume":"345","author":"N Saunders","year":"1995","unstructured":"Saunders N (1995) Pelvic exenteration: by whom and for whom? Lancet 345:5\u20136","journal-title":"Lancet"},{"key":"534_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF02505321","volume":"259","author":"F Numa","year":"1997","unstructured":"Numa F, Ogata H, Suminami Y et al (1997) Pelvic exenteration for the treatment of gynecological malignancies. Arch Gynecol Obstet 259:133\u2013138","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"534_CR17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/IGC.0b013e3181a8351e","volume":"19","author":"S Marnitz","year":"2009","unstructured":"Marnitz S, Dowdy S, Lanowska M et al (2009) Exenterations 60\u00a0years after first description: results of a survey among US and German Gynecologic Oncology Centers. Int J Gynecol Cancer 19(5):974\u2013977","journal-title":"Int J Gynecol Cancer"},{"key":"534_CR18","unstructured":"Forner DM, Lampe B (2011) Exenteration as a primary treatment for locally advanced cervical cancer: long-term results and prognostic factors. Am J Obstet Gynecol 205:148.e1\u20136"},{"key":"534_CR19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2011.03.003","volume":"122","author":"T Benn","year":"2011","unstructured":"Benn T, Brooks RA, Zhang Q et al (2011) Pelvic exenteration in gynecologic oncology: a single institution study over 20\u00a0years. Gynecol Oncol 122:14\u201318","journal-title":"Gynecol Oncol"},{"key":"534_CR20","unstructured":"National Comprehensive Cancer Network (2006) NCCN clinical practice guidelines in oncology cervical cancer V2.2006. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf"},{"key":"534_CR21","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ygyno.2006.06.027","volume":"103","author":"S Marnitz","year":"2006","unstructured":"Marnitz S, Kohler C, Muller M et al (2006) Indication for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol 103:1023\u20131030","journal-title":"Gynecol Oncol"},{"key":"534_CR22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jso.21518","volume":"101","author":"C Fotopoulou","year":"2010","unstructured":"Fotopoulou C, Neumann U, Kraetschell R et al (2010) Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies. J Surg Oncol 101:507\u2013512","journal-title":"J Surg Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-013-0534-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-013-0534-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-013-0534-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T12:46:52Z","timestamp":1562676412000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-013-0534-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,13]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1007\/s10147-013-0534-9","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,13]]}}}